Get notified when NUS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Goodwill Impairment (unchanged) — Manufacturing reporting unit recorded $78.9M goodwill impairment in Q2 2026 due to stock-price decline and forecast deterioration.
Revenue fell 17.1% to $320.1M; goodwill impairment and tax allowance drove Q2 EPS to $(5.14)
Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 8, 2025 · ~2 min read
Key Changes
-
high
Q2 2026 revenue fell 17.1% YoY to $320.1M (vs 12% decline in Q2 2025), driven by macroeconomic challenges, Prysm iO product-transition friction, and sales-compensation-plan changes.
MD&A: Revenue verify on EDGAR → -
high
Q2 2026 EPS swung to $(5.14) from $0.43 in Q2 2025, driven by a $78.9M goodwill impairment on the manufacturing segment, a $167.5M U.S. deferred-tax valuation allowance, and operating loss of $59.3M.
MD&A: Earnings per Share verify on EDGAR → -
high
Company established $167.5M valuation allowance against U.S. deferred tax assets in Q2 2026, citing three-year cumulative U.S. losses from goodwill and intangible impairments; effective tax rate was (295.4)%.
Notes: Income Taxes verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CRWD 10-Q) is open in full — no account needed.
Partner
Trade NUS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 11, 2026 · How we verify